Cynthia Monesa Crago Clark

Person

Loveland, OH, US

People

Patents Grantslast 30 patents

Information Patent Grant
Human protein tyrosine phosphatase inhibitors and methods of use
- Patent number 10,463,650
- Issue date Nov 5, 2019
- Aerpio Pharmaceuticals, Inc.
- Jeffrey Lyle Gray
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Human protein tyrosine phosphatase inhibitors and methods of use
- Patent number RE46592
- Issue date Oct 31, 2017
- Aerpio Therapeutics, Inc.
- Jeffrey Lyle Gray
Information Patent Grant
Human protein tyrosine phosphatase inhibitors and methods of use
- Patent number 9,795,594
- Issue date Oct 24, 2017
- Aerpio Therapeutics, Inc.
- Jeffrey Lyle Gray
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Human protein tyrosine phosphatase inhibitors and methods of use
- Patent number 9,284,285
- Issue date Mar 15, 2016
- Aerpio Therapeutics, Inc.
- Jeffrey Lyle Gray
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Human protein tyrosine phosphatase inhibitors and methods of use
- Patent number 9,126,958
- Issue date Sep 8, 2015
- Aerpio Therapeutics, Inc.
- Jeffrey Lyle Gray
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Human protein tyrosine phosphatase inhibitors and methods of use
- Patent number 8,946,232
- Issue date Feb 3, 2015
- Aerpio Therapeutics, Inc.
- Jeffrey Lyle Gray
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Human protein tyrosine phosphatase inhibitors and methods of use
- Patent number 8,895,563
- Issue date Nov 25, 2014
- Aerpio Therapeutics, Inc.
- Jeffrey Lyle Gray
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Human protein tyrosine phosphatase inhibitors and methods of use
- Patent number 8,846,685
- Issue date Sep 30, 2014
- Aerpio Therapeutics Inc.
- Jeffrey Lyle Gray
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Human protein tyrosine phosphatase inhibitors and methods of use
- Patent number 8,338,615
- Issue date Dec 25, 2012
- Aerpio Therapeutics Inc.
- Jeffrey Lyle Gray
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Human protein tyrosine phosphatase inhibitors and method of use
- Patent number 8,329,916
- Issue date Dec 11, 2012
- Aerpio Therapeutics Inc.
- Kande K. D. Amarasinghe
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Human protein tyrosine phosphatase inhibitors and methods of use
- Patent number 8,258,311
- Issue date Sep 4, 2012
- Aerpio Therapeutics Inc.
- Jeffrey Lyle Gray
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Human protein tyrosine phosphatase inhibitors and methods of use
- Patent number 8,188,125
- Issue date May 29, 2012
- Aerpio Therapeutics Inc.
- Jeffrey Lyle Gray
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Human protein tyrosine phosphatase inhibitors and methods of use
- Patent number 8,106,078
- Issue date Jan 31, 2012
- Warner Chilcott Company, LLC
- Jeffrey Lyle Gray
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Human protein tyrosine phosphatase inhibitors and methods of use
- Patent number 7,795,444
- Issue date Sep 14, 2010
- Warner Chilcott Company
- Jeffrey Lyle Gray
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Human protein tyrosine phosphatase inhibitors and methods of use
- Patent number 7,622,593
- Issue date Nov 24, 2009
- The Procter & Gamble Company
- Jeffrey Lyle Gray
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Human protein tyrosine phosphatase inhibitors and methods of use
- Patent number 7,589,212
- Issue date Sep 15, 2009
- Procter & Gamble Company
- Jeffrey Lyle Gray
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
1,2-dihydropyrazol-3-ones which controls inflammatory cytokines
- Patent number 6,677,337
- Issue date Jan 13, 2004
- The Procter & Gamble Company
- Matthew John Laufersweiler
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE
- Publication number 20220117946
- Publication date Apr 21, 2022
- Aerpio Pharmaceuticals, Inc.
- Jeffrey Lyle Gray
- Y02 - TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMA...
Information Patent Application
HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE
- Publication number 20200253936
- Publication date Aug 13, 2020
- Aerpio Pharmaceuticals, Inc.
- Jeffrey Lyle Gray
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE
- Publication number 20180221346
- Publication date Aug 9, 2018
- AERPIO THERAPEUTICS, INC.
- Jeffrey Lyle Gray
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE
- Publication number 20160374996
- Publication date Dec 29, 2016
- AERPIO THERAPEUTICS, INC.
- Jeffrey Lyle Gray
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE
- Publication number 20150210656
- Publication date Jul 30, 2015
- AERPIO THERAPEUTICS, INC.
- Jeffrey Lyle Gray
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE
- Publication number 20140221666
- Publication date Aug 7, 2014
- Aerpio Therapeutics Inc.
- Jeffrey Lyle Gray
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE
- Publication number 20130324558
- Publication date Dec 5, 2013
- Aerpio Therapeutics Inc.
- Jeffrey Lyle Gray
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE
- Publication number 20130096140
- Publication date Apr 18, 2013
- Aerpio Therapeutics Inc.
- Jeffrey Lyle Gray
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE
- Publication number 20130023543
- Publication date Jan 24, 2013
- Aerpio Therapeutics Inc.
- Jeffrey Lyle Gray
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE
- Publication number 20130023542
- Publication date Jan 24, 2013
- Aerpio Therapeutics Inc.
- Jeffrey Lyle Gray
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE
- Publication number 20120077853
- Publication date Mar 29, 2012
- Jeffrey Lyle Gray
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHOD OF USE
- Publication number 20120077975
- Publication date Mar 29, 2012
- Jeffrey Lyle Gray
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE
- Publication number 20110212951
- Publication date Sep 1, 2011
- Jeffery Lyle Gray
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE
- Publication number 20100069448
- Publication date Mar 18, 2010
- Jeffrey Lyle Gray
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE
- Publication number 20100016336
- Publication date Jan 21, 2010
- Jeffrey Lyle Gray
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE
- Publication number 20090227639
- Publication date Sep 10, 2009
- Jeffrey Lyle Gray
- C07 - ORGANIC CHEMISTRY

Cynthia Monesa Crago Clark

Person

Patents Grantslast 30 patents

Human protein tyrosine phosphatase inhibitors and methods of use

Human protein tyrosine phosphatase inhibitors and methods of use

Human protein tyrosine phosphatase inhibitors and methods of use

Human protein tyrosine phosphatase inhibitors and methods of use

Human protein tyrosine phosphatase inhibitors and methods of use

Human protein tyrosine phosphatase inhibitors and methods of use

Human protein tyrosine phosphatase inhibitors and methods of use

Human protein tyrosine phosphatase inhibitors and methods of use

Human protein tyrosine phosphatase inhibitors and methods of use

Human protein tyrosine phosphatase inhibitors and method of use

Human protein tyrosine phosphatase inhibitors and methods of use

Human protein tyrosine phosphatase inhibitors and methods of use

Human protein tyrosine phosphatase inhibitors and methods of use

Human protein tyrosine phosphatase inhibitors and methods of use

Human protein tyrosine phosphatase inhibitors and methods of use

Human protein tyrosine phosphatase inhibitors and methods of use

1,2-dihydropyrazol-3-ones which controls inflammatory cytokines

Patents Applicationslast 30 patents

HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE

HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE

HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE

HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE

HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE

HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE

HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE

HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE

HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE

HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE

HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE

HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHOD OF USE

HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE

HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE

HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE

HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE